Synnex FPT sẵn sàng cho đích đến tỷ đô vào nửa đầu quý 4 techz.vn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from techz.vn Daily Mail and Mail on Sunday newspapers.
New trial results show that pembrolizumab given both before and after surgery for stage 2B-3 melanoma improved event-free survival compared with adjuvant therapy alone.
Triplet therapy for advanced renal cell carcinoma may soon be an option, after results show that adding cabozantinib to dual immune checkpoint inhibition improved progression-free survival.
An innovative study of short-course nivolumab plus ipilimumab prior to resection of MMR-deficient colon cancer has achieved unprecedented pathologic responses, with no recurrences.
Six months of adjuvant nivolumab plus ipilimumab after nephrectomy for renal cell carcinoma offers no disease-free survival benefit, reveals trial that highlights treatment duration and tolerability.